MI 63;(2'R,3S,3'S,5'R)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-(2-morpholin-4-ylethyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide;Spiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide, 6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-[2-(4-morpholinyl)ethyl]-2-oxo-, (2'R,3S,4'S,5'R)-
MI63 is used to activate p53 by targeting MDM2 (Ki = 3 nM); it inhibits the proliferation of embryonal and alveolar rhabdomyosarcoma cells (ERMS and ARMS) (IC50 = 0.58 μM in RH36 cells) and induces apoptosis in ERMS and ARMS cells.